Home LiteratureArticle Details
PMID: 756469 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin.

Journal of clinical & laboratory immunology ·Vol. 1 ·No. 3 ·1978-11-00 ·Pages 197-9

Goodwin JS, Bankhurst AD, Murphy SA, Selinger DS, Messner RP, Williams RC

Abstract

We administered indomethacin (25 mg q.i.d.) to two patients with common variable immunodeficiency and measured the effect on their depressed cellular immune responses. The in vitro response of both patients' lymphocytes to phytohemagglutinin increased during indomethacin administration. Both patients were anergic to skin testing before treatment and responded to two of four skin tests during treatment with indomethacin. Thus indomethacin administration in vivo appears to enhance the cellular immune respone, paralleling its previously described effects in vitro.

MeSH Terms
Adolescent Candida/immunology Cell Membrane/immunology Humans Immunity, Cellular/drug effects Immunologic Deficiency Syndromes/drug therapy Indomethacin/therapeutic use Lymphocyte Activation Male Middle Aged Mumps virus/immunology Phytohemagglutinins/pharmacology Skin Tests Trichophyton/immunology Tuberculin/immunology
Chemicals
Phytohemagglutinins Tuberculin Indomethacin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Goodwin J S
Bankhurst A D
Murphy S A
Selinger D S
Messner R P
Williams R C
Article Info
Journal
Journal of clinical & laboratory immunology
Abbr.
J Clin Lab Immunol
ISSN
0141-2760
Published
1978-11-00
Pages
197-9
Language
English
Region
Scotland
NLM ID
7808987
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]